RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kingworld Medicines Group - Stock

Kingworld Medicines Group ROE 2024

Kingworld Medicines Group ROE

0.06

Ticker

1110.HK

ISIN

KYG5268M1006

In 2024, Kingworld Medicines Group's return on equity (ROE) was 0.06, a 66.59% increase from the 0.04 ROE in the previous year.

Kingworld Medicines Group Aktienanalyse

What does Kingworld Medicines Group do?

Kingworld Medicines Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Kingworld Medicines Group's Return on Equity (ROE)

Kingworld Medicines Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Kingworld Medicines Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Kingworld Medicines Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Kingworld Medicines Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Kingworld Medicines Group Stock

What is the ROE (Return on Equity) of Kingworld Medicines Group this year?

The ROE of Kingworld Medicines Group this year is 0.06 undefined.

How has the Return on Equity (ROE) of Kingworld Medicines Group developed compared to the previous year?

The ROE of Kingworld Medicines Group has increased by 66.59% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Kingworld Medicines Group?

A high ROE indicates that Kingworld Medicines Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Kingworld Medicines Group?

A low ROE can indicate that Kingworld Medicines Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Kingworld Medicines Group affect the company?

A change in ROE (Return on Equity) of Kingworld Medicines Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Kingworld Medicines Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Kingworld Medicines Group?

Some factors that can influence Kingworld Medicines Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Kingworld Medicines Group pay?

Over the past 12 months, Kingworld Medicines Group paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 4.74 %. For the coming 12 months, Kingworld Medicines Group is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Kingworld Medicines Group?

The current dividend yield of Kingworld Medicines Group is 4.74 %.

When does Kingworld Medicines Group pay dividends?

Kingworld Medicines Group pays a quarterly dividend. This is distributed in the months of July, June, July, July.

How secure is the dividend of Kingworld Medicines Group?

Kingworld Medicines Group paid dividends every year for the past 13 years.

What is the dividend of Kingworld Medicines Group?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 4.74 %.

In which sector is Kingworld Medicines Group located?

Kingworld Medicines Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kingworld Medicines Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kingworld Medicines Group from 6/30/2024 amounting to 0.034 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Kingworld Medicines Group pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Kingworld Medicines Group in the year 2023?

In the year 2023, Kingworld Medicines Group distributed 0.024 CNY as dividends.

In which currency does Kingworld Medicines Group pay out the dividend?

The dividends of Kingworld Medicines Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kingworld Medicines Group

Our stock analysis for Kingworld Medicines Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kingworld Medicines Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.